Watchlist Price Alert

Aeglea BioTherapeutics In... (AGLE)

NASDAQ: AGLE · Real-Time Price · USD

12.01

0.75 (6.66%)

At close: Nov 27, 2023, 9:00 PM

Aeglea BioTherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	34.86M	15.14M	90.09M	19.25M	22.46M	12.82M	47.75M
Short-Term Investments	20.85M	77.99M	56.18M	52.7M	52.05M	37.48M	15.75M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	2.24M	2.68M	1.96M	1.57M	50K	232K	40K
Receivables	375K	815K	n/a	n/a	n/a	3.08M	1.22M
Inventory	n/a	-815K	n/a	n/a	n/a	n/a	n/a
Other Current Assets	6.17M	5.76M	3.52M	2.56M	2.16M	n/a	n/a
Total Current Assets	62.26M	98.89M	149.79M	74.5M	76.67M	54.99M	66.42M
Property-Plant & Equipment	6.65M	8.36M	9.87M	7.11M	1.02M	854K	599K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	8.89M	11.04M	11.83M	8.68M	1.07M	1.09M	639K
Total Assets	71.14M	109.93M	161.62M	83.18M	77.74M	56.08M	67.06M
Account Payables	677K	3.32M	2.25M	3.15M	663K	389K	168K
Deferred Revenue	517K	2.36M	13.41M	14.38M	n/a	20K	71K
Short-Term Debt	625K	436K	319K	351K	n/a	5.06M	3.5M
Other Current Liabilities	12.84M	14.03M	464K	469K	9.58M	159K	227K
Total Current Liabilities	14.66M	20.14M	16.44M	18.36M	10.24M	5.63M	3.96M
Long-Term Debt	4M	4.61M	5.13M	4.71M	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	16K	214K	31K	72K	111K	132K
Total Long-Term Liabilities	6.18M	5.84M	5.34M	4.74M	72K	111K	132K
Total Liabilities	20.84M	25.98M	21.79M	23.1M	10.31M	5.74M	4.1M
Total Debt	4.63M	5.04M	5.45M	5.06M	n/a	n/a	n/a
Common Stock	6K	5K	5K	3K	2K	2K	1K
Retained Earnings	-425.62M	-341.81M	-276.01M	-195.12M	-116.86M	-72.51M	-45.28M
Comprehensive Income	-48K	-20K	11K	51K	-27K	-102K	-4K
Shareholders Equity	50.3M	83.94M	139.83M	60.08M	67.43M	50.34M	62.97M
Total Investments	20.85M	77.99M	56.18M	52.7M	52.05M	37.48M	15.75M